Primary thyroid angiosarcoma: A systematic review
- PMID: 29909901
- DOI: 10.1016/j.oraloncology.2018.05.004
Primary thyroid angiosarcoma: A systematic review
Erratum in
-
Corrigendum to 'Primary thyroid angiosarcoma: A systematic review' [Oral Oncol. 82 (2018) 48-52].Oral Oncol. 2019 Apr;91:137. doi: 10.1016/j.oraloncology.2019.02.016. Epub 2019 Feb 26. Oral Oncol. 2019. PMID: 30824286 No abstract available.
Abstract
Thyroid angiosarcoma (TAS) is rare and represents a very aggressive malignancy. Its rarity is principally linked to two major pitfalls. Firstly, TAS histopathology diagnosis can be difficult; second, the limited clinical experience with this condition can make its management complex. We conducted a detailed systematic review, focusing on the knowledge available regarding TAS etiopathogenesis, treatment options and prognosis. The aim is to present the main TAS characteristics and to summarize the clinical experiences described worldwide, in order to provide a useful clinical tool.
Keywords: Angiosarcoma; Chemotherapy; Radiotherapy; Sarcoma; Surgery; Therapy; Thyroid; Treatment.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases